“…In this context, we evaluate whether bladder dysfunction was a good target for this treatment. Current interventions used to reduce bladder dysfunction after SCI include cholinergic muscarinic receptor antagonists [ 79 , 80 , 81 , 82 , 83 , 84 , 85 ], chemical blockade of C-fiber afferent neurotransmission with capsaicin or resiniferatoxin [ 86 , 87 , 88 , 89 , 90 , 91 , 92 ] and alpha1- acetylcholine receptor (AR) receptor antagonists [ 93 , 94 , 95 , 96 , 97 , 98 , 99 ]. Additional interventions include suppression of motorneuron or interneuron excitation in the spinal cord by glycine, GABA agonists, and baclofan is being used to treat dysfunctional contraction of the external urethral sphincter [ 100 , 101 , 102 , 103 , 104 , 105 , 106 ].…”